113 related articles for article (PubMed ID: 3399677)
1. Mass spectrometric identification of urinary and plasma metabolites of 9-hydroxy-19,20-bis-nor-prostanoic acid (rosaprostol).
Benfenati E; Fanelli R; Chiabrando C; Valcavi U; Bosone E; Farina P
Prostaglandins; 1988 May; 35(5):665-84. PubMed ID: 3399677
[TBL] [Abstract][Full Text] [Related]
2. Serum and urine kinetics of rosaprostol in volunteers.
Segre G; Fiaschi AI; Bianchi E; Ciani D; Tedeschi S
Arzneimittelforschung; 1988 Dec; 38(12):1846-9. PubMed ID: 3245860
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin cytoprotection in man: effectiveness of rosaprostol.
Foschi D; Trabucchi E; Galeone M; Ferrante F; Toti GL; Castoldi L; Musazzi M; Centemero A; Montorsi W
Int J Tissue React; 1988; 10(1):53-7. PubMed ID: 3397253
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric identification of urinary and plasma metabolites of 6-(6'-carboxyhexyl)-7-n-hexyl-1,3-diazaspiro-[4-4]-nonan-2,4-dione, a new cytoprotective agent.
Benfenati E; Fanelli R; Bosone E; Biffi C; Caponi R; Cianetti M; Farina P
Drug Metab Dispos; 1991; 19(5):913-6. PubMed ID: 1686235
[TBL] [Abstract][Full Text] [Related]
5. The effects of 9-hydroxy-19,20-bis-norprostanoic acid on mucus, acid and gastrin secretion in duodenal ulcer patients.
Foschi D; Ferrante F; Callioni F; Bastagli A; Rovati V
Prostaglandins Leukot Med; 1984 Aug; 15(2):147-52. PubMed ID: 6593741
[TBL] [Abstract][Full Text] [Related]
6. Platelet function, platelet prostanoids and vascular prostacyclin in diabetes mellitus.
Hendra T; Betteridge DJ
Prostaglandins Leukot Essent Fatty Acids; 1989 Mar; 35(4):197-212. PubMed ID: 2654960
[No Abstract] [Full Text] [Related]
7. Nonprotein sulfhydryls as possible components of the protective effect of rosaprostol on the rat gastric mucosa.
Fumagalli R; Caponi R; Corsini A; Brambilla A; Palmira M; Bernini F; Valcavi U
Prostaglandins; 1985 Mar; 29(3):467-74. PubMed ID: 3858913
[TBL] [Abstract][Full Text] [Related]
8. Gastric antisecretory, antiulcer and cytoprotective properties of 9-hydroxy-19,20-bis-nor-prostanoic acid in experimental animals.
Valcavi U; Caponi R; Brambilla A; Palmira M; Minoja F; Bernini F; Musanti R; Fumagalli R
Arzneimittelforschung; 1982; 32(6):657-63. PubMed ID: 7202371
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of duodenal ulcer with rosaprostol in patients resistant to treatment with anti-H2].
Tincani GP; Maniscalco G; Gunelli M; Ciarrocchi V
Minerva Med; 1987 Jun; 78(12):847-53. PubMed ID: 2885786
[TBL] [Abstract][Full Text] [Related]
10. [Further observations of the inhibitory effect of the disodium salt of 9-hydroxy-8,12-trans-19,20-bis-norprostanoic acid (rosaprostol) on gastric secretion].
Adami M; Scarpignato C; Signorini G; Coruzzi G; Bertaccini G
Farmaco Prat; 1984 Nov; 39(11):409-16. PubMed ID: 6526080
[No Abstract] [Full Text] [Related]
11. [Cytoprotective effect of rosaprostol during treatment with non-steroidal anti-inflammatory agents in arthrorheumatic pathologies].
Cataldo MG; Sallì L; Scalici G; D'Aiuto A; Bongiorno A; Salerno L
Minerva Dietol Gastroenterol; 1989; 35(3):191-4. PubMed ID: 2601868
[TBL] [Abstract][Full Text] [Related]
12. Effects of a synthetic prostanoid, rosaprostol, on the changes of gastric acidity and digestive disorders induced by NSAID.
Di Murro R; Camarri E; Ciani D; Mariotti L; Nencioni C; Romagnoli AM
Int J Clin Pharmacol Res; 1988; 8(5):345-51. PubMed ID: 3068160
[TBL] [Abstract][Full Text] [Related]
13. Short- and long-term treatment with rosaprostol of patients with gastritis.
Di Simone A; Riegler G; Esposito P; Ciani D
Int J Clin Pharmacol Res; 1988; 8(3):217-21. PubMed ID: 3403108
[TBL] [Abstract][Full Text] [Related]
14. [Prophylactic rosaprostol treatment of gastro-duodenal disorders caused by corticoid therapy].
Ghiringhelli P
Clin Ter; 1987 Feb; 120(4):309-15. PubMed ID: 2953531
[No Abstract] [Full Text] [Related]
15. Profiles of prostaglandin metabolites in the human circulation. Identification of late-appearing, long-lived products.
Granström E; Kindahl H; Swahn ML
Biochim Biophys Acta; 1982 Oct; 713(1):46-60. PubMed ID: 6958332
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of (+/-)-homosarkomycin and (+/-)-rosaprostol.
Tanimori S; Kainuki T; Nakayama M
Biosci Biotechnol Biochem; 1992 Nov; 56(11):1807-9. PubMed ID: 1369076
[No Abstract] [Full Text] [Related]
17. Synthesis of Enantiomerically Pure Stereomers of Rosaprostol.
Łukasik B; Perlikowska W; Żurawiński R; Mikołajczyk M
J Org Chem; 2015 Oct; 80(19):9798-802. PubMed ID: 26355965
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunoassays for prostaglandin metabolites.
Granström E; Kindahl H
Adv Prostaglandin Thromboxane Res; 1976; 1():81-92. PubMed ID: 63236
[TBL] [Abstract][Full Text] [Related]
19. Prostanoids and cancer.
Bennett A
Ann Clin Res; 1984; 16(5-6):314-7. PubMed ID: 6398665
[No Abstract] [Full Text] [Related]
20. A new strategy for cyclopentenone synthesis.
Trost BM; Pinkerton AB
Org Lett; 2000 Jun; 2(11):1601-3. PubMed ID: 10841489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
